Roivant Sciences Ltd.
NASDAQ:ROIV
11.07 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -187.101 | 57.49 | -182.496 | 5,072.665 | -331.118 | -327.845 | -148.178 | -352.014 |
| Depreciation & Amortization
| 1.818 | 4.883 | 5.225 | 5.385 | 5.587 | 5.839 | 7.509 | 6.966 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 50.191 | 46.724 | 54.325 | 49.318 | 49.26 | 0 | 0 |
| Change In Working Capital
| 10.31 | -68.735 | 15.955 | 21.195 | 17.127 | -35.242 | 21.182 | 2.741 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 7.21 | -25.267 | 20.887 | -8.345 | -1.798 | 11.94 | -9.611 | 7.196 |
| Other Working Capital
| 3.1 | -43.468 | -4.932 | 29.54 | 18.925 | -47.182 | 30.793 | -4.455 |
| Other Non Cash Items
| -91.833 | -236.658 | 6.135 | -5,364.022 | 62.659 | 58.056 | -59.601 | 119.714 |
| Operating Cash Flow
| -266.806 | -192.829 | -108.457 | -210.452 | -196.427 | -249.932 | -179.088 | -222.593 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -0.996 | -0.965 | -0.349 | -0.355 | -0.275 | -0.403 | -1.622 | -0.508 |
| Acquisitions Net
| 110.387 | 0 | -0.804 | 0 | 0 | 0 | 0 | -3.091 |
| Purchases Of Investments
| -3,402.985 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 8.081 | 5,233.396 | -36.176 | 0.508 | 115.175 | 0.088 |
| Investing Cash Flow
| -3,293.594 | -0.965 | 6.928 | 5,233.041 | -36.451 | 0.105 | 113.553 | -3.511 |
| Financing Activities: | ||||||||
| Debt Repayment
| -1.833 | -7.665 | -7.662 | -7.57 | -7.808 | -7.808 | -8.036 | -7.423 |
| Common Stock Issued
| 7.268 | 0 | 238.733 | 238.733 | 221.528 | 0 | 219.807 | 163.031 |
| Common Stock Repurchased
| -106.054 | -648.385 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -6.184 | -24.959 | 5.568 | -23.291 | 15.858 | 15.285 | -1.439 | -1.113 |
| Financing Cash Flow
| -109.074 | -660.616 | -32.624 | 236.639 | 207.872 | 7.477 | 210.332 | 154.495 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 5.043 | -2.74 | -0.855 | 3.042 | -1.454 | -0.117 | 0 | 0 |
| Net Change In Cash
| -3,664.431 | -857.15 | -135.008 | 5,262.27 | -26.46 | -242.467 | 0 | 0 |
| Cash At End Of Period
| 1,969.914 | 5,693.3 | 6,550.45 | 6,685.458 | 1,423.188 | 1,449.648 | 1,681.824 | 1,531.405 |